Other languages Roquefort Therapeutics plc

Equities

ROQ

GB00BMDQ2T15

Delayed London S.E. Other stock markets 04:02:28 28/06/2024 pm IST			5-day change	1st Jan Change
4.6 ^GBX	-4.17%		+4.55%	-36.55%

23/05	Windward wins deal; Kodal progresses at Bougouni	AN
23/05	Roquefort Therapeutics plc Announces Executive and Board Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Windward wins deal; Kodal progresses at Bougouni	24/05
Roquefort Therapeutics plc Announces Executive and Board Changes	23/05
EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany	27/04
Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Roquefort cancels fundraise after "unusual" stock movements	05/04
Roquefort celebrates "significant milestones" in cancer research	11/03
Roquefort Therapeutics plc Provides an Update on the Development of the Midkine Midkine mRNA and STAT-6 siRNA programs	11/03
Roquefort hails further MK studies, licence talks continue	06/02
Roquefort Therapeutics plc Provides an Update on Its Pre-Clinical Drug Development Programs	06/02
Roquefort Therapeutics Announces Significant Mesodermal Killer Cell Milestone	06/11
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO	27/23/27
Roquefort Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	27/23/27
Roquefort files patent application for mRNA and RNA therapies	14/23/14
Roquefort Therapeutics Files International Patent for Anti-cancer Therapeutics	14/23/14
Roquefort Therapeutics plc Announces the Successful Filing of the International Phase PCT Patent for Its Proprietary Anti-Cancer mRNA and RNA Oligonucleotide Therapeutics	14/23/14
Roquefort announces new sirNA sequences and patent filing	07/23/07
Roquefort Therapeutics Completes Development of Four Novel Small Interfering RNA Sequences; Shares Up 5%	07/23/07
Anpario trading in line, Likewise Group sales rise	29/23/29
Plant Health Care announces GBP2.8 million fundraise	23/23/23
Roquefort Therapeutics Expects Q4 Closing for In Vivo Studies for Anti-Cancer Program	22/23/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Roquefort Therapeutics plc

Equities

ROQ

GB00BMDQ2T15

Other languages

Filters